FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to oncology, and can be used for treating initial stages of tongue cancer. Day before the surgery, the peritumoral introduction of 99mTc radiopharmaceutical with activity of 40–60 MBq is performed. Under the control of radioisotopic mapping, a sentinel node is surgically removed to assess the pathological condition of the regional metastasis areas. Further, pin sources Cf-252 are installed in place of primary source.
EFFECT: method provides pathomorphological control of zones of regional metastasis and preservation of the functional state of the affected organ ensured by brachytherapy and regional metastasis control.
1 cl, 9 dwg, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF TREATING ORAL CANCER | 2019 |
|
RU2713530C2 |
| METHOD OF ORGAN-PRESERVING TREATMENT OF SQUAMOUS CELL CARCINOMA OF ORAL MUCOSA cT1N0M0 WITH DEPTH OF TUMOUR INVASION UP TO 5 mm | 2023 |
|
RU2824427C2 |
| METHOD FOR TARGETED BRACHYTHERAPY OF PROSTATE CANCER UNDER HYBRID PSMA-RECEPTOR SCINTIGRAPHY NAVIGATION | 2022 |
|
RU2788859C2 |
| METHOD OF INTRAOPERATIVE PHOTODYNAMIC THERAPY IN COMBINED TREATMENT OF PRIMARY LOCALLY ADVANCED TONGUE CANCER | 2022 |
|
RU2797433C1 |
| METHOD FOR TREATING OROPHARYNGEAL SQUAMOUS CELL CARCINOMA | 2018 |
|
RU2689875C2 |
| METHOD OF TREATING SQUAMOUS ORAL CANCER AND PHARYNX | 2019 |
|
RU2715550C2 |
| METHOD OF TREATING SQUAMOUS ORAL CANCER AND PHARYNX IN COMBINATION WITH RADIATION AND DRUG EXPOSURE | 2019 |
|
RU2705109C2 |
| METHOD FOR DIFFERENTIATED TREATMENT OF PATIENTS WITH LOCALIZED BREAST CANCER | 2017 |
|
RU2637859C1 |
| METHOD FOR TREATMENT OF SQUAMOUS CELL P-16 POSITIVE OROPHARYNGEAL CANCER | 2020 |
|
RU2751818C2 |
| SENTINEL LYMPH NODES DIAGNOSING METHOD IN GASTRIC CANCER | 2020 |
|
RU2727251C2 |
